[Clinical evaluation of the hypotensive action of mebutamate (2-sec-butyl-2-methyl-1,3-propanediol dicarbamate)].
D000959:Antihypertensive Agents / Q000628:therapy*; D014150:Antipsychotic Agents; D006801:Humans; D007022:Hypotension; D011409:Propylene Glycols
D000959:Antihypertensive Agents; D014150:Antipsychotic Agents; D011409:Propylene Glycols; C041787:1,3-propanediol; C437090:2-methyl-1,3-propanediol
ANTIHYPERTENSIVE AGENTS/therapy